Decreased Oral Bioavailability of Lansoprazole in Healthy Volunteers when Given with a Standardised Breakfast

Clinical Drug Investigation

Volumn 9, Issue 2, 1995, Pages 67-71

  Bergstrand, Robert ^a   Grind, Margaretha ^a   Nyberg, Gunnar ^a   Olofsson, Bertil ^a  

^a ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

LANSOPRAZOLE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; FEEDING; FOOD DRUG INTERACTION; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0028929458     PISSN: 11732563     EISSN: 11791918     Source Type: Journal    
DOI: 10.2165/00044011-199509020-00002     Document Type: Article

References (6)

1. Lansoprazole. A review of its pharmacodynamic properties and its therapeutic efficacy in acid-related disorders
2. The effect of food and antacids on lansoprazole absorption and disposition
3. Gastric acid inhibition by the proton pump inhibitor lansoprazole is unaffected by food
4. Determination of omeprazole and metabolites in plasma and urine by liquid chromatography
5. Effect of omeprazole — a gastric proton pump inhibitor — on pentagastrin stimulated acid secretion in man
6. When do ulcer patients take their acid inhibiting medication?